Not applicableStudy completedNCT00229658
What this trial is testing
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
AstraZeneca 1,297